Exact Mass: 515.0867

Exact Mass Matches: 515.0867

Found 29 metabolites which its exact mass value is equals to given mass value 515.0867, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

3-ADP-glyceric acid

C13H19N5O13P2 (515.0455)

Cefozopran

C19H17N9O5S2 (515.0794)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DE - Fourth-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D01052

dTDP-4-amino-2,3,4,6-tetradeoxy-D-glucose

dTDP-4-amino-2,3,4,6-tetradeoxy-D-glucose; dTDP-[(2R,5S,6R)-5-aminotetrahydro-6-methyl-2H-pyran-2-yl] ester; dTDP-4-amino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranose

C16H27N3O12P2 (515.107)

Coenzyme F420-0

C19H22N3O12P (515.0941)

L-lactyl-2-diphospho-5-guanosine

(2S)-Lactyl-2-diphospho-5-guanosine

C13H19N5O13P2 (515.0455)

Cefozopran

1-({7-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(methoxyimino)acetamido]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl}methyl)imidazo[1,2-b]pyridazin-1-ium

C19H17N9O5S2 (515.0794)

Chloroquine Phosphate

Chloroquine diphosphate

C18H32ClN3O8P2 (515.1353)

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Dicycloplatin

C12H20N2O8Pt (515.0867)

ethyl 5-(benzyloxy)-6-broMo-2-((cyclohexylthio)Methyl)-1-Methyl-1H-indole-3-carboxylate

C26H30BrNO3S (515.113)

1,3-Dicaffeoylquinate

C25H23O12- (515.1189)

A quinate that is the conjugate base of 1,3-dicaffeoylquinic acid.

6-O-malonylononin

C25H23O12- (515.1189)

Isochloric acid c

C25H23O12- (515.1189)

reduced coenzyme F420-0

C19H22N3O12P-2 (515.0941)

(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C22H23N6O5S2+ (515.1171)

7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetyl]amino]-3-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C19H17N9O5S2 (515.0794)

[(2R,3S,4R,5R)-3,4-dihydroxy-5-[2-[(1-hydroxy-2-oxopropyl)amino]-6-oxo-1H-purin-9-yl]oxolan-2-yl]methyl phosphono hydrogen phosphate

C13H19N5O13P2 (515.0455)

dTDP-4-amino-2,3,4,6-tetradeoxy-alpha-D-glucose

C16H27N3O12P2 (515.107)

A pyrimidine nucleotide-sugar having thymine as the nucleobase and 4-amino-2,3,4,6-tetradeoxy-alpha-D-glucose as the sugar component.

PSB-12379

C18H23N5O9P2 (515.0971)

PSB-12379, a nucleotide analogue, is a potent Ecto-5'-Nucleotidase (CD73) inhibitor with Kis of 9.03 nM (rat) and 2.21 nM (human)[1][2].

2,3,6,20,23,27-hexahydroxy-4-methyl-15-azaheptacyclo[14.12.0.0²,⁷.0³,¹⁴.0⁸,¹³.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-1(16),8,10,12,17(26),19,21,23,27-nonaene-5,18,25-trione

C28H21NO9 (515.1216)

(10r)-3,24-dihydroxy-23-methoxy-10-methyl-9,20-dioxa-6-azaheptacyclo[15.12.0.0²,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁹,²⁸.0²¹,²⁶]nonacosa-1(17),2,4(12),13,19(28),21,23,25-octaene-5,18,27,29-tetrone

(10r)-3,24-dihydroxy-23-methoxy-10-methyl-9,20-dioxa-6-azaheptacyclo[15.12.0.0²,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁹,²⁸.0²¹,²⁶]nonacosa-1(17),2,4(12),13,19(28),21,23,25-octaene-5,18,27,29-tetrone

C28H21NO9 (515.1216)

(2r,3s,4r,6r,7r,14s)-2,3,6,20,23,27-hexahydroxy-4-methyl-15-azaheptacyclo[14.12.0.0²,⁷.0³,¹⁴.0⁸,¹³.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-1(16),8,10,12,17(26),19,21,23,27-nonaene-5,18,25-trione

(2r,3s,4r,6r,7r,14s)-2,3,6,20,23,27-hexahydroxy-4-methyl-15-azaheptacyclo[14.12.0.0²,⁷.0³,¹⁴.0⁸,¹³.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-1(16),8,10,12,17(26),19,21,23,27-nonaene-5,18,25-trione

C28H21NO9 (515.1216)

[(2r,5s,6r)-5-amino-6-methyloxan-2-yl]oxy([hydroxy([(2r,3s,5r)-3-hydroxy-5-(4-hydroxy-5-methyl-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy)phosphoryl]oxy)phosphinic acid

C16H27N3O12P2 (515.107)

4,4-dichloro-n-{5,5-dichloro-4-methyl-1-[4-methyl-2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]-1-oxopentan-2-yl}-n,3-dimethylbutanamide

C20H29Cl4N3O2S (515.0734)

(10r)-3,18,24,29-tetrahydroxy-23-methoxy-10-methyl-9,20-dioxa-6-azaheptacyclo[15.12.0.0²,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁹,²⁸.0²¹,²⁶]nonacosa-1(17),2(14),3,12,15,18,21,23,25,28-decaene-5,27-dione

(10r)-3,18,24,29-tetrahydroxy-23-methoxy-10-methyl-9,20-dioxa-6-azaheptacyclo[15.12.0.0²,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁹,²⁸.0²¹,²⁶]nonacosa-1(17),2(14),3,12,15,18,21,23,25,28-decaene-5,27-dione

C28H21NO9 (515.1216)